MENU
VNDA
AS OF
Feb 4, 02:25 PM (EDT)
Price
$7.63
Change
-$0.41 (-5.09%)
Capitalization
475.73M
7 days until earnings call
Intraday BUY SELL Signals
+Compare
VNDA
Stock ticker: NASDAQ
AS OF
Feb 4, 02:25 PM (EDT)
Price
$7.63
Change
-$0.41 (-5.09%)
Capitalization
475.73M

VNDA Vanda Pharmaceuticals Forecast, Technical & Fundamental Analysis

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients... Show more

Industry: #Biotechnology
VNDA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for VNDA with price predictions
Feb 03, 2026

VNDA saw its Stochastic Oscillator leaves the overbought zone

The Stochastic Oscillator for VNDA moved out of overbought territory on January 28, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 59 similar instances where the indicator exited the overbought zone. In of the 59 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for VNDA moved out of overbought territory on January 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for VNDA turned negative on January 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VNDA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VNDA broke above its upper Bollinger Band on December 31, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 23, 2026. You may want to consider a long position or call options on VNDA as a result. In of 100 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VNDA advanced for three days, in of 253 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 130 cases where VNDA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VNDA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.021) is normal, around the industry mean (27.519). P/E Ratio (126.000) is within average values for comparable stocks, (51.491). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.893). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (2.229) is also within normal values, averaging (331.843).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VNDA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
VNDA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

VNDA is expected to report earnings to rise 156.58% to -97 cents per share on February 11

Vanda Pharmaceuticals VNDA Stock Earnings Reports
Q4'25
Est.
$-0.98
Q3'25
Beat
by $0.05
Q2'25
Missed
by $0.17
Q1'25
Missed
by $0.48
Q4'24
Beat
by $0.09
The last earnings report on October 29 showed earnings per share of -37 cents, beating the estimate of -43 cents. With 199.55K shares outstanding, the current market capitalization sits at 475.73M.
A.I. Advisor
published General Information

General Information

a manufacturer of biopharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2200 Pennsylvania Avenue NW
Phone
+1 202 734-3400
Employees
203
Web
https://www.vandapharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DHIAX22.530.18
+0.81%
Diamond Hill International Inv
RALIX11.260.02
+0.18%
Lazard Real Assets Instl
MPLAX16.93-0.03
-0.18%
Praxis International Index A
JHIGX36.99-0.07
-0.19%
JHancock International Growth R2
MUERX35.75-0.37
-1.02%
MFS Blended Research Core Equity R1

VNDA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VNDA has been loosely correlated with IVF. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if VNDA jumps, then IVF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNDA
1D Price
Change %
VNDA100%
+4.01%
IVF - VNDA
40%
Loosely correlated
-6.45%
OLMA - VNDA
37%
Loosely correlated
+1.91%
MGTX - VNDA
37%
Loosely correlated
+2.68%
VCYT - VNDA
36%
Loosely correlated
-1.10%
JAZZ - VNDA
36%
Loosely correlated
-0.27%
More